Early outcomes of active surveillance for localized prostate cancer. - Wikidata - wikimedia - TriplyDB

Early outcomes of active surveillance for localized prostate cancer.

Early outcomes of active surveillance for localized prostate cancer.

http://www.wikidata.org/entity/Q39713992

about

Radical prostatectomy versus watchful waiting for prostate cancer Watchful waiting versus prostatectomy for prostate cancer Outcomes of localized prostate cancer following conservative management Active surveillance and focal therapy for low-intermediate risk prostate cancer Can contemporary patients with biopsy Gleason score 3+4 be eligible for active surveillance?The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397).Screening for prostate cancer: the debate continues Evolution from active surveillance to focal therapy in the management of prostate cancer.A multi-institutional evaluation of active surveillance for low risk prostate cancer.Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention?Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.Active surveillance for low-risk prostate cancer.Quality of life in men undergoing active surveillance for localized prostate cancer.The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk.Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer.Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment.Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview The '2-week wait' rule for referrals for suspected urological cancers--urgent need for refinement of criteria.Watchful waiting and active surveillance: the current position.The routine use of prostate-specific antigen for early detection of cancer prostate in India: Is it justified?Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study.Critical review: is watchful waiting a viable management option for older men with prostate cancer?Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure.Active surveillance for low-risk prostate cancer: an update.Role of histopathology and molecular markers in the active surveillance of prostate cancer.Formalized prediction of clinically significant prostate cancer: is it possible?Active surveillance for prostate cancer: overview and update.Active surveillance for low-risk prostate cancer: diversity of practice across Europe.Management of low risk prostate cancer-active surveillance and focal therapy.Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.Feasibility for active surveillance in biopsy Gleason 3 + 4 prostate cancer: an Australian radical prostatectomy cohort.Active surveillance for low-risk non-muscle-invasive bladder cancer: mid-term results from the Bladder cancer Italian Active Surveillance (BIAS) project.The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance ca Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy.Anejaculation as an atypical presentation of prostate cancer: a case report.Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?A model of the natural history of screen-detected prostate cancer.

P2860

Q24236564-AB2CE582-8B50-4395-82A2-41156CC97B68 Q24244913-33A318CA-1D50-4A02-9748-CF1F91DD0F66 Q24647380-485F4054-01A2-4D7B-920C-31C48E4E8172 Q26773641-BDC74708-DF7E-4068-87ED-39438559F093 Q28543448-C006BC38-95E4-4826-8559-B775763E2BBA Q31083661-E7E39980-D189-45B8-AECB-26EECC5EBFEB Q33885776-F5A5F3AF-4BEA-4F29-B13D-5C5CBC1C5152 Q33933490-FA064E1C-AEA7-4AD6-BB74-0B1513E233F3 Q34541484-799C0C3B-709D-423F-B490-A2B2D1B33580 Q34659767-6A955599-A838-4814-B382-97717BB6B77F Q34861407-6F98CAF9-A129-49BE-8A9B-8CD624A48015 Q35806400-3E70D4E7-53C5-4802-AEF2-959D51FEF01F Q36141777-A01A97DF-26A3-43E8-8CAC-B60152479130 Q36520543-AE959407-0582-4847-BFF0-CF4EEAFB81E6 Q36613795-A3A934C6-C39B-4BB2-9665-622E08544E8D Q36728850-69655D0B-AB32-45C3-AD04-5760FBE47BAC Q36757436-DEAF123A-CF98-4630-874F-0583AA5B379E Q36837246-4CF13BFF-9994-441E-B251-2117926EBB32 Q36979944-D83349BC-DBB8-4FF6-B28E-CC9244FB9468 Q37108357-6C853379-6EC7-4FF2-87D5-3766E04606A1 Q37142197-2A2D88F9-5979-4FC8-BF20-4D6E8737A577 Q37260341-C3E7D960-0397-4969-AC31-C640FAA612BC Q37287476-A165971B-83E1-4AC8-8442-1EE23F7A0781 Q37502285-3CCA3DFE-5228-4F27-A4B7-03C0FABE4353 Q37810318-A6BE6C6D-9BD8-483B-8A6E-707CE2EE68C6 Q37868926-072BE118-4A1C-4ABD-98DF-6AD09F98F7FA Q37878468-20D9809B-0650-473A-BAB6-B986E0BA5856 Q37988363-1F9E687C-7186-4959-B27C-D09DF0BB8864 Q38074079-4BBCCA8D-B454-4F6A-B209-1B39A9B287AC Q38197935-F0192688-23E2-4E71-A8E9-3ABA0DEC1169 Q38211360-384A10F7-D3F8-4A67-8B75-B246782FCC1E Q38350249-A9A16614-A42B-4050-AAC2-245D5DEADBBB Q38812336-1F85E236-5D42-494E-9639-2A4709656711 Q39748314-26D0F938-73BC-43C6-A94E-CBAB785D4DBE Q40856884-F6F3843C-C8DD-4815-BF75-B2F3FD3C0EED Q40875442-E4231629-F623-4FE9-A921-C0D77345C0DA Q41320663-AFC837DB-2B11-4282-BEA7-FCC52A121253 Q41972830-DE769712-8D58-477F-BC33-C049DA242E08 Q43101073-49F75166-29A2-404E-9D6B-26C790FA6DA1 Q43199658-0FC600E0-3622-4396-89E1-01E898595F23

P2860

Early outcomes of active surveillance for localized prostate cancer.

http://www.wikidata.org/entity/Q39713992

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Early outcomes of active surveillance for localized prostate cancer.

@en

Early outcomes of active surveillance for localized prostate cancer.

@nl

type

label

Early outcomes of active surveillance for localized prostate cancer.

@en

Early outcomes of active surveillance for localized prostate cancer.

@nl

prefLabel

Early outcomes of active surveillance for localized prostate cancer.

@en

Early outcomes of active surveillance for localized prostate cancer.

@nl

P1433

Q39713992-6D358BF7-BA52-4912-AB40-67DBD406868F

P1476

Q39713992-AE21338C-803A-4115-8138-D563159AA7AF

P2093

Q39713992-3E4DA9D6-3A1D-4DA1-95AB-6EE2B240B869

Q39713992-76AA8016-D853-4F97-BCAC-648E8C29DF7F

Q39713992-99A941E1-8FAB-457D-9C6B-B40B6D854DF8

Q39713992-E672C54A-7B27-441D-AA98-08B9564BDF95

Q39713992-ED3528F6-F10E-40F9-8BA9-CBB6493E397A

Q39713992-FA80C88B-C62E-4EA0-9865-B753ED6FCDB4

Q39713992-FE52573F-BCBD-4A15-B226-A4516E2892AE

P2860

Q39713992-170DDD42-A287-4618-A011-7DA0B34E24E7

Q39713992-8C651C38-3AF4-4B6B-8E33-8DE5520943B4

Q39713992-A85D3E77-F351-47B9-A2CE-59D53D47B4DF

Q39713992-FB5E4576-381F-4AD1-95A8-A9887D82EA8F

P304

Q39713992-CC5624B6-3BBE-48FE-8C5F-090E700A065B

P31

Q39713992-BEC75C16-FA5E-4DF9-A9A4-5AA608EBB00F

P356

Q39713992-DF03F344-C928-4DBB-AB4F-7F018B42286E

P407

Q39713992-DE82076D-B816-4B6A-B4F7-A127CAB83562

P433

Q39713992-AC0B660D-7DC5-43DC-BC8A-F7C6784458C0

P478

Q39713992-69EF9B1B-2002-4436-A5DC-4096CC74A940

P577

Q39713992-6EFF4B3E-2048-4246-AA4B-F773F3155B49

P5875

Q39713992-92C606ED-2088-4A15-A218-C694D3D55450

P698

Q39713992-29598A60-44D3-4E94-9A2A-1E939C895732

P356

J.1464-410X.2005.05446.X

P1433

BJU International

P1476

Early outcomes of active surveillance for localized prostate cancer.

@en

P2093

Alan Horwich

http://www.w3.org/2001/XMLSchema#string

Andrew Norman

http://www.w3.org/2001/XMLSchema#string

Chris Parker

http://www.w3.org/2001/XMLSchema#string

Claire Hardie

http://www.w3.org/2001/XMLSchema#string

David Dearnaley

http://www.w3.org/2001/XMLSchema#string

Robert Huddart

http://www.w3.org/2001/XMLSchema#string

Ros Eeles

http://www.w3.org/2001/XMLSchema#string

P2860

The management of PSA failure after radical radiotherapy for localized prostate cancer.

Active surveillance: towards a new paradigm in the management of early prostate cancer.

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

P304

956-960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2005.05446.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7897352

http://www.w3.org/2001/XMLSchema#string

P698

15839912

http://www.w3.org/2001/XMLSchema#string